Brief: NGM Bio Announces Poster Presentation Featuring Preclinical Characterization Of NGM936 At Upcoming 2022 ASH Annual Meeting
04/11/2022 12:04
Nov 4 (Reuters) - NGM Biopharmaceuticals Inc NGM.O :
* NGM BIO ANNOUNCES POSTER PRESENTATION FEATURING
PRECLINICAL
CHARACTERIZATION OF NGM936 AT UPCOMING 2022 ASH ANNUAL MEETING
Source text for Eikon: ID:nGNX3Vrn0C
Further company coverage: NGM.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on NGM Biopharmaceuticals
See all newsBrief: NGM Biopharmaceuticals Q4 Net Income USD -27.67 Million
Brief: NGM Bio Enters into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group
NGM Biopharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Ngm Biopharmaceuticals Says It Got Written Notice From Nasdaq Informing It Has Regained Compliance With Nasdaq Listing
Brief: NGM Bio Announces New Clinical Data From Ongoing Trial Of Ngm707 In Advanced Solid Tumors